{"chebi_id":"76612","chebi_name":"ibrutinib","chebi_synonyms":["1-{(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl}prop-2-en-1-one","IMBRUVICA","PCI-32765","PCI32765","PCI 32765","ibrutinibum"],"diffprof_id_observed":["MTBLS2871_0002_00000009"],"diffprof_id_var_observed":["MTBLS2871_0002_00000009"],"inchikey":"XYFPWWZEPKGCCK-GOSISDBHSA-N","inn_name":"ibrutinib","iupac_name":"1-{(3<i>R</i>)-3-[4-amino-3-(4-phenoxyphenyl)-1<em>H</em>-pyrazolo[3,4-<em>d</em>]pyrimidin-1-yl]piperidin-1-yl}prop-2-en-1-one","num_study_observed":1,"reactome_ids":["R-HSA-1266695","R-HSA-1280215","R-HSA-1280218","R-HSA-1643685","R-HSA-168256","R-HSA-449147","R-HSA-451927","R-HSA-5663205","R-HSA-6785807","R-HSA-8985947","R-HSA-9020558","R-HSA-9679191","R-HSA-9679506","R-HSA-9824446","R-HSA-983695","R-HSA-983705"],"reactome_names":["Interleukin-7 signaling","Cytokine Signaling in Immune system","Adaptive Immune System","Disease","Immune System","Signaling by Interleukins","Interleukin-2 family signaling","Infectious disease","Interleukin-4 and Interleukin-13 signaling","Interleukin-9 signaling","Interleukin-2 signaling","Potential therapeutics for SARS","SARS-CoV Infections","Viral Infection Pathways","Antigen activates B Cell Receptor (BCR) leading to generation of second messengers","Signaling by the B Cell Receptor (BCR)"],"study_id_observed":["MTBLS2871"],"study_id_var_observed":["MTBLS2871"],"synonym_name":"PCI-32765"}